Cargando…
The in vitro Evaluation of the Activity of COVID-19 Antiviral Drugs Against Adenovirus
PURPOSE: Presently, there is no approved antiviral therapy for adenovirus (HAdV) ocular infections. During the COVID-19 pandemic, increased attention has been focused on antiviral treatments. Remdesivir, hydroxychloroquine, ivermectin, and umifenovir (Arbidol) have been touted as potential antiviral...
Autores principales: | Romanowski, Eric G, Yates, Kathleen A, Romanowski, John E, Shanks, Robert M Q, Kowalski, Regis P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866980/ https://www.ncbi.nlm.nih.gov/pubmed/35221670 http://dx.doi.org/10.2147/OPTH.S340576 |
Ejemplares similares
-
Filociclovir Is an Active Antiviral Agent against Ocular Adenovirus Isolates In Vitro and in the Ad5/NZW Rabbit Ocular Model
por: Romanowski, Eric G., et al.
Publicado: (2021) -
Ranpirnase (OKG-0301), a Novel Ribonuclease, Demonstrates Antiviral Activity against Adenovirus in the Ad5/NZW Rabbit Ocular Replication Model
por: Romanowski, Eric G., et al.
Publicado: (2022) -
Topical Astodrimer Sodium, a Non-Toxic Polyanionic Dendrimer, Demonstrates Antiviral Activity in an Experimental Ocular Adenovirus Infection Model
por: Romanowski, Eric G., et al.
Publicado: (2021) -
Cyclopentenylcytosine (CPE-C): In Vitro and In Vivo Evaluation as an Antiviral against Adenoviral Ocular Infections
por: Romanowski, Eric G., et al.
Publicado: (2023) -
Speciation and Antibiotic Susceptibilities of Coagulase Negative Staphylococci Isolated from Ocular Infections
por: Romanowski, John E., et al.
Publicado: (2021)